WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-1.23%)Nav, as on 13-02-2026

  • Previous Nav

  • Net Change on 13-02-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 5.78 22.32 14.62 1.83 7,875.40
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 3.96 26.15 16.41 1.86 6,658.41
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 2.74 24.20 15.61 1.94 3,822.73
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 2.67 21.88 14.37 2.14 1,239.57
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 5.91 23.93 14.58 2.28 1,055.01

Fund Holdings as on 31-January-2026

  • Sun Pharmaceutical Industries Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Divi's Laboratories Limited

  • Fortis Healthcare Limited

  • Lupin Limited

  • Apollo Hospitals Enterprise Limited

  • Max Healthcare Institute Limited

  • Laurus Labs Limited

  • Alkem Laboratories Limited

  • Krishna Institute Of Medical Sciences Limited

  • Net Receivables / (Payables)

  • Ajanta Pharma Limited

  • Neuland Laboratories Limited

  • Sai Life Sciences Limited

  • Corona Remedies Limited

  • Acutaas Chemicals Limited

  • Narayana Hrudayalaya Limited

  • Shaily Engineering Plastics Limited

  • Abbott India Limited

  • Navin Fluorine International Limited

  • Vijaya Diagnostic Centre Limited

  • Emcure Pharmaceuticals Limited

  • AstraZeneca Pharma India Limited

  • Pfizer Limited

  • Eris Lifesciences Limited

  • Kovai Medical Center and Hospital Limited

  • Strides Pharma Science Limited

  • Aether Industries Limited

  • Thyrocare Technologies Limited

  • Aarti Pharmalabs Limited

  • Sudeep Pharma Limited

  • Supriya Lifescience Limited

  • Zota Health Care Limited

  • Jupiter Life Line Hospitals Limited

  • 91 Days Tbill (MD 12/03/2026)

  • Cipla Limited

  • IPCA Laboratories Limited

  • Poly Medicure Limited

  • Dr.Agarwals Eye Hospital Limited

  • Shilpa Medicare Limited

  • Anthem Biosciences Limited

  • 182 Days Tbill (MD 19/02/2026)

  • Orchid Pharma Limited

  • Mankind Pharma Limited

  • 182 Days Tbill (MD 12/02/2026)

  • 364 Days Tbill (MD 19/03/2026)

  • 91 Days Tbill (MD 19/02/2026)

  • 182 Days Tbill (MD 19/03/2026)

  • 364 Days Tbill (MD 05/02/2026)

  • 91 Days Tbill (MD 26/02/2026)

  • 182 Days Tbill (MD 09/04/2026)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Chemicals

  • Miscellaneous

  • Plastic Products

  • Trading

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

  • Sov

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹491.85 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended down ₹-0.17(-1.23%)yesterday to ₹13.574.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643